HIGHLIGHTS
- What: The authors have chosen the drug methotrexate to investigate the efficacy of the delivery vector. The authors attempt a strategy to deliver the drug methotrexate for therapeutic purposes in triple-negative breast cancer cells using cell-penetrating peptides with different electrostatic signatures and geometry.
- Who: Electrostatic potential and collaborators from the Indian Institute of Technology Guwahati Department of Biosciences and Bioengineering have published the article: Structural Regression Modelling of Peptide based Drug Delivery Vectors for the Treatment of Triple-Negative Breast Cancer, in the Journal: (JOURNAL)
- How: The following day the cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.